Félix Gutiérrez

Has grant

Professor of Medicine

Universidad Miguel Hernández de Elche

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Félix Gutiérrez is a Professor of Medicine at Universidad Miguel Hernández de Elche, Spain. His research primarily focuses on HIV-related health issues, including the impact of gut microbiota on weight gain and viral suppression therapies. He has also explored early cancer detection methodologies for persons living with HIV and the evaluation of T-cell immunity in response to COVID-19 variants.

Recent Grants

Grant: Open

IMpacto de un Programa Ampliado de Cribado en la detección de NEOplasiasmalignas no-sida en pacientes con infección por el VIH (IMPAC-NEO)

Open Date: 2021-01-01

Close Date: 2031-12-01

Grant: Close

Desarrollo de un asistente virtual inteligente destinado a la población con VIH

Open Date: 2021-01-01

Close Date: 2023-12-01

Grant: Close

Estudio piloto para evaluar la eficacia y seguridad de la mefloquina como profilaxis en personas expuestas a la enfermedad producida por coronavirus SARS-CoV-2 (COVID-19).

Open Date: 2020-04-01

Close Date: 2021-04-01

Grant: Close

Red española de Investigación en Sida (RIS).

Open Date: 2017-01-01

Close Date: 2021-12-01

Grant: Close

Influencia de la composición del microbioma intestinal en la progresión de la arteriosclerosis en pacientes con infección por el VIH en tratamiento antirretroviral eficaz.

Open Date: 2017-01-01

Close Date: 2017-09-01

Articles (17)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (17)

Julie fox

University College London

UNITED KINGDOM

Félix Gutiérrez

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (17)

Gut microbiota and weight gain in people with HIV on integrase inhibitors: a five-year longitudinal study

Insights on Drug Levels and Non-Sustained Viral Suppression With Long-Acting Cabotegravir and Rilpivirine Therapy

Early Detection of Cancer and Precancerous Lesions in Persons With HIV Through a Comprehensive Cancer Screening Protocol

“Editorial comment on: Increased incidence of diabetes in people living with HIV treated with first‐line integrase strand transfer inhibitors: A French multicentre retrospective study”

Virological History Predicts Non-sustained Viral Suppression with Long-Acting Cabotegravir and Rilpivirine Therapy, independent of Pharmacokinetic Parameters

The persistence of low CD4/CD8 ratio in chronic HIV-infection, despite ART suppression and normal CD4 levels, is associated with pre-therapy values of inflammation and thymic function

T-Cell Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 Measured by an Interferon-γ Release Assay Is Strongly Associated With Patient Outcomes in Vaccinated Persons Hospitalized With Delta or Omicron Variants

Unplanned pregnancies and social and partner support during pregnancy in Spanish women living with HIV

Identification of pre-infection markers and differential plasma protein expression following SARS-CoV-2 infection in people living with HIV

Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial.

Improving Recognition of Fracture Risk in People with Human Immunodeficiency Virus: Performance and Model Contribution of Two Common Risk Assessment Tools

Integrating SARS-CoV-2-specific interferon-γ release assay testing in the evaluation of patients hospitalized with COVID-19

Predictors of low‐level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort

Pericarditis caused by Mycobacterium africanum: case report

Immunologic phenotype of patients with long-COVID syndrome of 1-year duration

Human Immunodeficiency Virus Type 1 RNA Levels in Rectal and Seminal Compartments After Switching to Long-Acting Cabotegravir Plus Rilpivirine: A Longitudinal Study

Clinical performance of a standardized SARS-CoV-2 interferon-γ release assay for simple detection of T-cell responses after infection or vaccination

Collaborators (17)

Julie fox

Asuncion Hernando

Carlos Malvestutto

Enrique Martin‐Gayo

Enrique Barrajón-Catalán

Agnese Marino

Chloe Orkin

Eduardo Malmierca Corral

Mar Masiá

ALICIA GONZALEZ-BAEZA

Esther Rodríguez-Gallego

Yolanda María Pacheco

JOSE ALBERTO GARCIA GOMEZ

Josep M. Llibre

Santiago Moreno

Marta Rava

CHRISTINE KATLAMA

Make your next move.